Biotech VC Funds

Main Sequence Ventures, founded in 2017 and backed by Australia's national science agency CSIRO, is a venture capital firm that focuses on deep tech and frontier technologies. The firm is headquartered in Australia and aims to solve significant global challenges through its investments. Main Sequence has a unique "venture science" model, which starts by identifying big challenges and bringing together science, people, and investment to create and fund companies that can address these issues. Main Sequence Ventures has built a strong portfolio with notable companies such as Q-CTRL, which makes quantum technology useful; Gilmour Space, which focuses on efficient satellite launches; and Emesent, a leader in robotics and autonomy technology. Other significant investments include Myriota, which provides low-cost satellite connectivity, and V2food, which develops sustainable meat alternatives. The firm's second fund, which raised $250 million, focuses on areas such as decarbonization, healthcare, and space technology. This fund supports companies like Kasada, a cybersecurity firm stopping bot attacks, and RapidAIM, which offers biosecurity solutions for pest management. Main Sequence Ventures is dedicated to leveraging scientific discoveries to create impactful, high-growth companies that can address some of the world's most pressing challenges. Their strategic investment approach and strong support for portfolio companies highlight their commitment to driving innovation and technological advancement globally.

Majycc Capital is a prominent French venture capital firm that focuses on revolutionizing the healthcare sector through strategic investments in innovative startups. Established in 2022 through the merger of Majycc eSanté Invest and UI Investissement, the firm now manages over €700 million, primarily dedicated to eHealth, MedTech, and BioTech ventures. Majycc Capital is particularly active in the Series A and B funding stages, where it seeks out high-potential startups across France and Europe that are positioned to deliver transformative advancements in healthcare. The firm's investment strategy goes beyond financial support. Leveraging its deep connections within the healthcare ecosystem, Majycc Capital provides comprehensive strategic assistance to its portfolio companies. This includes guidance on navigating complex regulatory pathways, insights into market dynamics, and support in business development—key elements that are crucial for scaling healthcare innovations. Majycc’s extensive network within the healthcare industry, including partnerships with healthcare manufacturers and private clinic groups, further amplifies the growth potential of the startups it backs. Majycc Capital’s commitment to innovation is underscored by its regional presence, with 13 offices throughout France, ensuring that it remains closely involved with local economies and emerging companies. The firm’s dedicated team, led by experienced professionals, is deeply invested in the success of its portfolio companies, working tirelessly to ensure they achieve their full potential in the competitive healthcare market​.

Maki.vc is a seed-stage venture capital firm that partners with deep tech and brand-driven startups focused on challenging category norms. Founded in 2018, Maki.vc invests in early-stage companies from their inception to Series A, emphasizing scientific advancements and unique customer understanding. Maki.vc has a global mandate, with a strong presence in the Nordics. The firm’s portfolio includes companies across various sectors such as AI, quantum computing, and sustainability. Notable investments include IQM, a leader in quantum computing; Spinnova, which develops sustainable textiles; and Onego Bio, which creates animal-free egg protein using novel technology. The firm’s approach goes beyond providing capital. Maki.vc supports its portfolio companies through Maki House, a platform that offers strategic guidance and a network of experts to help startups scale and achieve long-term success. Their investment philosophy centers on future-proofing companies by integrating ESG principles into their operations from the start, ensuring sustainability and long-term profitability.

Mana Ventures is a San Francisco-based venture capital firm that focuses on early to growth-stage investments, primarily in technology-driven sectors. Founded in 2016, the firm has built a diverse portfolio that includes companies across AI, software, consumer tech, healthtech, and more. Mana Ventures aims to back startups that are redefining industries through innovation, providing not only capital but also strategic support to help them scale. The firm’s portfolio features high-profile companies like Unity Technologies, a leading platform for game development, and Monarch, which focuses on AI-powered autonomous tractors. Mana Ventures is also known for its investments in companies like Synctera, a fintech software suite, and Odeko, which offers solutions for coffee businesses. Their strategic approach involves partnering with entrepreneurs from early stages and guiding them through product development, market expansion, and subsequent funding rounds. Mana Ventures emphasizes a hands-on approach, often leveraging its extensive network of LPs, founders, and industry specialists to support its portfolio companies. This network is designed to provide value beyond funding, including access to strategic partnerships, recruitment, and revenue-driving opportunities. With a keen focus on innovation and scalable tech solutions, Mana Ventures continues to shape and support startups that have the potential to lead their industries.

Mandashi is a Sheffield-based family office investment firm focused on supporting early-stage startups with innovative and impactful solutions. Founded by Dr. Andy Evans and Sheila Gupta, Mandashi aims to invest in sectors that address real-world challenges, emphasizing sustainability, healthcare, and technological advancements. The firm operates with a mission to mentor and inspire entrepreneurs, guiding them to build successful businesses that contribute positively to the community. Mandashi's portfolio reflects its commitment to diverse industries, with investments in companies like FourJaw, which enhances manufacturing productivity through data analytics, and Rarecan, a platform improving research for rare cancers. The firm also backs ventures such as Atelerix, which develops innovative methods for preserving biological materials, and GitLife Biotech, focusing on bio-asset intellectual property. The investment approach at Mandashi extends beyond capital; they provide strategic support and networking opportunities, helping startups transform their vision into scalable solutions. The firm actively promotes ethical business practices, long-term growth, and community engagement, highlighting their belief in responsible and sustainable entrepreneurship. Mandashi’s team, led by founders with a track record of successful ventures, brings deep expertise and a hands-on approach to every partnership.

Mandi Ventures is an early-stage venture capital fund based in São Paulo, Brazil, with additional offices in Brussels. The fund focuses on investing in disruptive technologies within the food, agriculture, and climate tech sectors. Mandi Ventures primarily targets startups involved in novel foods, biotech, life sciences, robotics, and precision farming, aiming to reshape how we produce and consume food. Their global investment reach includes startups across the Americas, Europe, and Israel. Mandi Ventures supports seed-stage companies, offering not just capital but also strategic business expertise to help startups commercialize their innovations. They focus on areas like supply chain logistics, wellness, sustainability, and SaaS platforms within the food and agriculture ecosystem. Notable investments include companies driving innovation in biotech and precision farming, ensuring that the fund stays at the forefront of transformative food technologies. With a strong network and industry connections, Mandi Ventures plays an active role in guiding its portfolio companies through their growth stages, from scaling operations to market expansion.

Manta Ray Ventures is an early-stage venture capital firm based in London, founded by Sebastian Kulczyk. The firm focuses on backing mission-driven founders who aim to address significant global challenges using advanced technologies. Manta Ray Ventures provides flexible and patient capital, leveraging their resources and networks to support their portfolio companies. Their diverse portfolio includes notable investments such as Volocopter, a manufacturer of electric copters for urban mobility; Astranis, a developer of satellite-based communication services; and Bluu Biosciences, focused on food and agriculture technology. They also have investments in companies like Epic Games, the creator of the popular game Fortnite, and Juvena Therapeutics, which is involved in drug discovery and clinical trials. Manta Ray Ventures has achieved significant exits, including the acquisition of Frontier Car Group by OLX Group and the merger of Forge Platform. The firm has also seen one of its portfolio companies, Bridge, go public on the Tokyo Stock Exchange. Led by a team of experienced professionals, including Managing Partner Lawrence Barclay and Partner Leah von Siemens, Manta Ray Ventures is dedicated to fostering innovation and supporting the growth of transformative technologies across various industries.

March Capital, established in 2014 and based in Santa Monica, California, is a venture growth firm focused on next-generation technology companies. The firm emphasizes sectors such as enterprise AI, fintech, and commerce enablement, aiming to partner with visionary entrepreneurs and support their growth to market leadership. Notable investments in March Capital's portfolio include CrowdStrike, a leader in cybersecurity; BillDesk, India's premier payments network; and Canva, an online design platform. They have also invested in companies like ActionIQ, a customer data platform, and ASAPP, an AI software company automating customer service. March Capital has seen successful exits from companies such as CarTrade, an online automotive marketplace, and Forescout, a cybersecurity firm. The firm is known for its collaborative approach, working closely with portfolio companies to provide strategic guidance and leveraging their extensive network to drive growth and success. They focus on building concentrated portfolios and doubling down on high-potential investments, ensuring significant impact and returns. March Capital also hosts The Montgomery Summit, a premier technology conference that gathers leading entrepreneurs, investors, and corporate executives to foster relationships and catalyze growth for portfolio companies.

Marcy Venture Partners (MVP), co-founded in 2018 by Shawn "JAY-Z" Carter, Jay Brown, and Larry Marcus, is a venture capital firm based in San Francisco. The firm focuses on investing in consumer and culture-driven companies that emphasize sustainability, inclusivity, accessibility, empowerment, and health & wellness. MVP's approach involves partnering with innovative businesses that are led by exceptional management teams and have strong brand values, outstanding products, and clear growth trajectories​. The firm has raised significant capital, closing its second fund with $325 million, bringing total assets under management to around $600 million. MVP has made investments in companies such as Therabody, Savage X Fenty, and Wheels, demonstrating a keen interest in diverse and impactful sectors. MVP is renowned for its robust support network and hands-on involvement, providing not just capital but also strategic guidance and industry connections to help its portfolio companies scale effectively​.

MarsBio is a Los Angeles-based venture capital fund that focuses on investing in pre-seed and seed-stage biotech startups. The firm specializes in biosciences and frontier technologies, targeting innovations in healthcare, therapeutics, synthetic biology, and the future of food. With check sizes ranging from $250K to $500K, MarsBio supports startups that push the boundaries of biology, using it as a tool for manufacturing and sustainable solutions. Their portfolio reflects an interest in companies working on immunology, oncology, neuroscience, and bio-enabling technologies, such as research tools and bioelectronics. Co-founded by Rob Rhinehart, best known for creating Soylent, MarsBio aims to back visionary founders with disruptive ideas. The firm emphasizes its support for entrepreneurs tackling complex problems, particularly those related to sustainable food supply chains and novel healthcare solutions. MarsBio’s strategy is to engage deeply with founders at the earliest stages, helping them scale innovative solutions that have the potential to redefine industries. MarsBio primarily invests in U.S.-based companies and leverages its expertise and network to drive transformational progress in biosciences. They’re especially drawn to startups that are pioneering new technologies that could shape the next era of healthcare and sustainable living.

Martlet Capital is an early-stage venture capital firm based in Cambridge, UK, focused on deep technology and life sciences B2B startups. Since its inception in 2011, Martlet Capital has invested in over 70 companies, providing patient capital to high-growth potential ventures. Their portfolio spans sectors like artificial intelligence, digital health, personalized medicine, engineering, IoT, new materials, and quantum technologies. Notable investments include Echion Technologies, known for their superfast-charging lithium-ion batteries, and IESO Digital Health, which provides real-time cognitive behavioral therapy online. They have also invested in companies like Converge, developing wireless sensor networks for real-time construction monitoring, and Dogtooth Technologies, which creates autonomous robots for productivity enhancement. Martlet Capital typically leads funding rounds and supports its portfolio companies beyond capital with strategic guidance, network access, and operational expertise. Their successful exits include Arachnys, Audio Analytic, and Cambridge CMOS Sensors. Martlet Capital's team comprises experienced investors and entrepreneurs, who actively engage in nurturing startups from early commercialization stages to scaling. Their investment strategy focuses on fostering innovation and driving growth in the UK, particularly within the Cambridge tech ecosystem. For startups seeking investment, Martlet Capital looks for innovative solutions with scalable business models in deep tech and life sciences. They prioritize strong leadership teams and groundbreaking technologies that can make a significant impact on their respective industries.

Marubeni Corporation, founded in 1858 and incorporated in 1949, is a prominent Japanese general trading company headquartered in Tokyo. The company operates across numerous sectors including lifestyle, IT solutions, food, agriculture, chemicals, metals and mineral resources, energy, power, infrastructure projects, aerospace, shipping, finance, leasing, real estate, and industrial machinery. Marubeni is committed to sustainability and innovation, aiming to create solutions that foster positive societal impact while maintaining financial performance. This commitment is reflected in their investments and operations across diverse industries worldwide. The company's philosophy of "Fairness, Innovation, and Harmony" drives its vision for a sustainable and prosperous future. The company has a robust global network with over 4,300 employees and numerous subsidiaries and affiliates, highlighting its significant presence and influence in the international market. Marubeni's extensive operations and strategic investments underscore its role as a key player in global trading and investment.

MassMutual Ventures (MMV) is a global venture capital firm that invests in a range of sectors, including enterprise software, cybersecurity, financial technology, digital health, and climate technology. Founded in 2014 and based in Boston, MMV also has offices in London and Singapore. The firm manages over $1 billion in investment capital and focuses on accelerating the growth of its portfolio companies by providing capital, connections, and strategic advice. Notable investments by MMV include Prove, a leader in digital identity solutions; Daye, a gynecological health startup; and Griffin, a developer-friendly Banking as a Service platform. The firm's portfolio spans across various stages of investment, from seed to growth stage, with typical check sizes ranging from $100,000 to $5 million. In 2022, MMV launched a $100 million Climate Technology Fund to invest in early and growth-stage companies addressing climate change. This fund aims to support 15 to 20 companies developing solutions to mitigate, measure, and manage climate change impacts, further expanding MMV's commitment to sustainable innovation​. The team at MMV includes experienced investors, former entrepreneurs, and operators, such as Doug Russell, the Managing Partner and Head of MMV, and Ryan Collins, the Managing Partner for Europe and APAC. Their deep industry expertise and extensive network help portfolio companies scale and succeed in competitive markets.

MassVentures, established in 1978 as the Massachusetts Technology Development Corporation, is a venture capital firm dedicated to supporting early-stage technology startups in Massachusetts. With a mission to bridge the capital gap for startups, MassVentures has invested $91.9 million in 152 companies from its inception through June 2019. The firm focuses on diverse sectors including life sciences, robotics, and advanced manufacturing, and typically makes initial investments of $250,000 to $500,000. Notable investments include Battery Resourcers, Inkbit, and Pison. Additionally, MassVentures administers the Small Business Innovation Research Targeted Technologies (SBIR-TT) grant program, which has awarded $22.1 million to 79 companies since 2012. This program supports the commercialization of innovations emerging from academic research and small businesses, fostering technological advancement and job creation in the state. MassVentures is led by an 11-member board of directors, predominantly from the private sector, and operates with a small team based in Boston. The firm not only provides financial support but also strategic guidance and operational expertise to help startups scale successfully. Through its investments and grant programs, MassVentures plays a crucial role in the growth of Massachusetts' innovation ecosystem, aiming to enhance the state's economic development by nurturing high-potential startups.

Material Impact, founded in 2015 by Adam Sharkawy and Carmichael Roberts, is a venture capital firm based in Boston, Massachusetts, that focuses on transforming material science innovations into impactful real-world applications. The firm is dedicated to addressing large-scale problems related to food, water, sustainable manufacturing, transportation, mobility, and healthcare through its investments in deep tech companies. Material Impact's portfolio includes notable companies such as DetraPel, Bloomer Tech, Folio Photonics, and Nohbo. These investments span a range of industries, including specialty chemicals, healthcare monitoring equipment, IT storage, and personal products. The firm’s hands-on approach to building companies involves working closely with founders to guide them through critical growth stages​. In 2023, Material Impact announced its $352 million Fund III, aimed at continuing its mission to support early-stage startups that leverage material science to solve pressing global challenges. This new fund allows Material Impact to take larger ownership stakes while maintaining its active role in company development. The firm's commitment to diversity and impact is reflected in its alignment with the United Nations Sustainable Development Goals and its diverse leadership team​. For entrepreneurs interested in partnering with Material Impact, the firm values innovations that have strong scientific foundations and the potential to address significant human needs. Material Impact provides not only capital but also strategic and operational support, often embedding its team members within portfolio companies to ensure their success.

Math Venture Partners, founded in 2014 and based in Chicago, Illinois, is an early to middle-stage venture capital firm that focuses on investing in digital and technical companies. The firm emphasizes supporting entrepreneurial teams with a strong focus on customer acquisition and operational efficiency, leveraging their extensive experience as operators who have built, scaled, and sold businesses valued at over $7 billion. The firm has a diverse portfolio across various sectors, including SaaS, marketplace businesses, and tech-enabled services. Notable investments include Acorns, a wealth-building platform; Built In, a national recruiting platform for technical and sales talent; Chowly, which helps restaurants manage their menus and connectivity to third-party tech; and NoRedInk, an e-learning platform that improves students' grammar and writing skills. Math Venture Partners is managed by seasoned investors and operators, including Managing Directors Mark Achler, Troy Henikoff, and Dana Wright. They have partnered with over 200 companies, focusing on providing both capital and strategic support to help them grow with greater certainty. Despite their success, the firm announced that they will not raise a third fund, citing the challenging fundraising environment and their commitment to fully supporting their current portfolio companies.

Matrix Partners is a powerhouse in early-stage venture capital, boasting over four decades of experience and $4 billion in assets under management. Their portfolio spans transformative startups like Canva, Afterpay, Oculus, and Hubspot, among 65+ IPOs and 110+ acquisitions. With offices in San Francisco and Boston, Matrix invests globally, focusing on the U.S., India, and China. Their sweet spot is in sectors like AI, fintech, digital health, and B2B SaaS. Matrix is known for its commitment to backing founders from seed through Series A, providing checks ranging from $100K to $1M. They emphasize patience, nurturing relationships with company builders and former founders, helping them scale effectively. While they often lead rounds, Matrix also co-invests, partnering with top VCs like Y Combinator and Andreessen Horowitz. Key team members include Pranay Desai and Paul Sherer in San Francisco, and they maintain a reputation for being hands-on, leveraging deep expertise across diverse tech-driven industries. Entrepreneurs seeking funding should approach Matrix with a clear vision for scalable innovation, as the firm is laser-focused on high-impact, technology-driven ventures.

Maven Ventures is a seed-stage venture capital firm specializing in consumer software startups. With a notable track record, Maven has backed major successes like Zoom, Cruise, and Epic!, achieving significant exits and IPOs. Founded in 2013, the firm has maintained a focused strategy, supporting around 50 high-potential startups with investments typically ranging from $750K to $1M. The firm is keenly interested in emerging consumer trends and technologies, investing in sectors like digital health, autonomous vehicles, fintech, and AI-driven solutions. Geographic focus primarily includes the United States, particularly Silicon Valley, but Maven also invests in global opportunities. Maven Ventures' strategy is highly selective, with a small team providing hands-on support to a concentrated portfolio. The team, led by seasoned investors like Jim Scheinman, focuses on building deep relationships with founders, offering critical guidance on marketing, product development, and go-to-market strategies. Recent investments include startups like Hello Heart, which provides mobile solutions for heart health, and Wildtype, a company pioneering lab-grown seafood. The firm has a proactive approach to diversity, supporting a range of women-led and minority-led startups. Maven Ventures prefers to be approached through a well-articulated pitch that demonstrates a strong market need and scalable solution. With a reputation for nurturing bold founders and transformative ideas, Maven Ventures remains a prominent player in the VC landscape, consistently driving innovation and impactful growth in the consumer tech sector​.

Maverick Ventures, established in 2015, is the venture capital arm of Maverick Capital, a multi-billion dollar investment firm. Based in San Francisco, Maverick Ventures focuses on early-stage and growth-stage investments, particularly in healthcare and technology sectors. The firm prides itself on combining the agility of a focused venture team with the extensive resources and reputation of a global investment firm. Maverick Ventures has built a diverse portfolio that includes notable companies such as Cityblock Health, Devoted Health, Collective Health, and Databricks. They typically support startups through seed to maturity stages, providing not just capital but also strategic guidance and operational support. The team at Maverick Ventures includes experienced investors like Lee Ainslie, who bring a wealth of expertise to their investments. The firm operates with an evergreen fund structure, allowing them to reinvest profits and continuously support their portfolio companies.

Maveron, a consumer-only venture capital firm, was founded in 1998 by Dan Levitan and Howard Schultz, the visionary behind Starbucks. The firm focuses on early-stage investments in transformative consumer brands. With a keen understanding of consumer behavior and market trends, Maveron has built a diverse portfolio that includes notable companies like Allbirds, Everlane, and Zulily. Maveron operates with a mission to back entrepreneurs who aim to change how people live, work, learn, play, eat, and stay well. Their investments span various consumer sectors such as health and wellness, e-commerce, and food innovation. Some of their prominent exits include eBay, Trupanion, and Potbelly Sandwich Works. The firm recently raised $225 million for its eighth fund, continuing its legacy of identifying and supporting early-stage consumer startups. Maveron's team, led by experienced partners like Dan Levitan and Jason Stoffer, brings deep industry knowledge and a commitment to fostering long-term partnerships with entrepreneurs.

Max Ventures, founded in 2013 by Ryan Darnell and Sophie Stenbeck, is a dynamic seed-stage venture capital firm based in New York. Notable for its early investments in companies like Boxed, ZoomCar, Button, and Drone Racing League, Max Ventures focuses on consumer tech and health-tech startups. The fund targets North American markets and emphasizes investing in founders with unique consumer insights and relentless drive. Max Ventures typically makes initial investments ranging from $750K to $1M, often leading the rounds. Their strategy involves a hands-on approach, leveraging their extensive network to support portfolio companies in achieving significant growth. The fund is particularly interested in startups within the fashion/beauty, food and beverage, internet and web services, real estate, and software industries. The team, including key figures like Managing Partner Matthew Weinberg, prides itself on its ability to identify and nurture innovative talent. Startups looking to approach Max Ventures should focus on demonstrating strong consumer insight and a clear execution plan. Recently, the firm has been active with investments like UnityAI in healthcare technology, showcasing their ongoing commitment to pioneering advancements in tech.

Mayfield is a renowned venture capital firm founded in 1969, with a focus on early-stage investments. The firm is based in Menlo Park, California, and has a strong presence in the U.S. and India. Mayfield has made significant contributions to the tech industry, backing over 852 companies, including notable names like Lyft, Couchbase, and Poshmark. Mayfield’s portfolio showcases a diverse range of sectors, emphasizing artificial intelligence, enterprise software, consumer tech, semiconductors, and human and planetary health. Some of their standout investments include Unstoppable Domains, Amagi, and BigPanda, which have grown into unicorns under their guidance. The firm has also successfully shepherded companies to IPO, such as Lyft and Couchbase, and facilitated numerous high-profile acquisitions. The firm operates with a "people-first" investment philosophy, aiming to partner with visionary entrepreneurs from inception through growth stages. They typically invest in Seed, Series A, and Series B rounds, providing not only capital but also strategic support and mentorship. Mayfield's investment team includes seasoned partners like Navin Chaddha and Ursheet Parikh, who bring extensive industry experience and a track record of successful exits. Mayfield's investment strategy involves close collaboration with founders, focusing on building enduring companies that can achieve market leadership. Founders looking to connect with Mayfield should highlight their innovative solutions and potential for significant impact, aligning with the firm’s mission to back transformative technologies.

MariaMazarine Ventures is a Chicago-based venture capital firm dedicated to addressing the global water crisis through technology. Founded in 2018, Mazarine exclusively invests in early-stage startups that are developing innovative solutions for managing water and wastewater-related risks across various industries. These sectors include agriculture, aquaculture, climate tech, and industrial applications, among others. The firm operates multiple funds, each with a unique focus. Fund II, for instance, targets companies with proven commercial traction—often nearing $1 million in annual sales—and intellectual property rooted in fields like chemistry, data science, and materials science. Mazarine typically leads seed and early Series A rounds, cutting checks between $25,000 and $500,000, and often continues to support its portfolio companies through follow-on investments. Mazarine’s investment strategy is centered on mitigating critical risks—such as public health, environmental protection, and business continuity—posed by water scarcity and quality issues. The firm’s approach extends beyond financial backing; it leverages a network of experienced operators and co-investors to provide strategic support, helping startups scale and achieve meaningful impact. The leadership team, including co-founders John Robinson, Pete Nassos, and Anders Hallsby, brings decades of experience in commercializing water and wastewater technologies. Mazarine’s rigorous focus on ESG (Environmental, Social, and Governance) metrics underscores its commitment to not only financial returns but also substantial environmental and social impact​. wll do on Thu

in 2001, MBVP primarily focuses on medical device startups, particularly those addressing musculoskeletal diseases. Notable investments include startups acquired by industry giants like Johnson & Johnson, Medtronic, Smith + Nephew, Zimmer Biomet, and Wright Medical (now part of Stryker). MBVP's strategy emphasizes providing not just capital but also strategic direction, leveraging their deep industry connections and expertise. They typically invest at all stages of development, ensuring that startups have the support they need from inception through to exit. The firm is known for its active role in the Musculoskeletal New Ventures Conference, a testament to its leadership in the sector. The team is led by co-founder Gary Stevenson, whose background includes significant roles in healthcare investment banking, equity research, and general management at Abbott Laboratories. Gary's comprehensive experience and his educational background, including an MBA from Northwestern University's Kellogg School of Management, underscore the firm's robust leadership. MBVP prefers to be approached by startups with a clear, compelling value proposition in the life sciences sector. They are known for writing substantial checks and often lead investment rounds. Their involvement in over 50 startups highlights their active investment approach and commitment to advancing medical innovations​.

MBX Capital, established in 2015, is a venture capital firm headquartered in Claymont, Delaware. The firm specializes in early-stage investments within the healthcare and life sciences sectors, focusing on pre-seed, seed, and Series A rounds. MBX Capital has a robust portfolio that includes companies like Luna, Concert Health, Koneksa Health, Atlas Labs, and Buoy Health​. Notable recent investments by MBX Capital include Vivodyne, which raised $38 million in November 2023, and Macro Trials, which secured $6 million in June 2023. These investments underline the firm's commitment to advancing biotechnology and clinical trials​ (PitchBook)​. Additionally, MBX Capital led a $10.7 million Series A financing for Contraline, supporting the development of innovative medical technologies​​. The firm's co-founders, Gurdane Bhutani and Zeshan Muhammedi, lead a team that provides hands-on support to portfolio companies, leveraging their expertise and extensive network to drive growth and innovation​​. MBX Capital's strategic approach and active involvement make it a key player in the venture capital landscape for healthcare and life sciences startups.

MD Start is a unique medtech incubator and fund based in Paris, dedicated to transforming early-stage medical device ideas into commercially viable companies. Founded in 2010, it partners with leading institutions like Medtronic, Bpifrance, and Sofinnova Partners to support innovative concepts that are too early for traditional venture investment. MD Start’s approach is hands-on, focusing on developing, managing, and de-risking projects to attract later-stage investment. The incubator primarily targets groundbreaking European medtech innovations, working closely with physicians and researchers to evaluate over 1,400 ideas, resulting in the creation of 7 companies. With expertise spanning product development, regulatory strategy, and clinical validation, MD Start ensures rapid and capital-efficient progress from idea to market. The team is led by experienced industry veterans like Gérard Hascoët, Anne Osdoit, and Lukas Guenther, who are instrumental in the incubator's success. Their focus is on turning early concepts into disruptive technologies, particularly in therapeutic devices and surgical tools. MD Start’s unique model and strong industry backing make it a vital player in Europe’s medtech landscape.

Medevice Capital is a Paris-based venture capital firm founded in 2011 that specializes in investing in early-stage MedTech and e-health startups. The fund primarily targets innovative companies in the healthcare sector, with a focus on medical devices and diagnostic technologies. Medevice typically invests in rounds ranging from $1 million to $5 million, supporting startups at the seed and later stages​. Some notable portfolio companies include Pixyl, which develops AI-driven medical imaging solutions, and Emagina, focused on women's health with a connected device for perineum care. Medevice also invested in Dyameo, which is working on cancer detection devices​. The firm is led by Cécile Réal, the founder and CEO, and its team has a strong background in healthcare entrepreneurship and investment. Medevice remains active, making approximately two investments per year, particularly within the European market.

Media Ventures, founded by Dirk Ströer, is a Cologne-based venture capital firm focusing on media, technology, telecommunications, and e-commerce sectors. Established in 2000, the firm has been instrumental in supporting innovative business models and emerging companies, primarily within Germany and Europe. Media Ventures seeks to empower entrepreneurs by providing both strategic investment and operational support, leveraging its deep-rooted expertise in media and advertising. The firm’s investment strategy revolves around backing early-stage to growth-stage companies that demonstrate potential for scalability and market leadership. Over the years, Media Ventures has built a diverse portfolio, including companies like aha.de, a longstanding player in the newsletter segment, and multiple digital marketing platforms. By maintaining a strong focus on digital and tech-based business models, the firm aligns its investments with the evolving media landscape, such as programmatic advertising, e-commerce solutions, and new media technologies. Dirk Ströer’s leadership has ensured that Media Ventures operates with a keen understanding of the industry's needs, often facilitating synergies between portfolio companies and his larger media empire, Ströer Group. This strategic integration helps startups scale faster by gaining access to comprehensive marketing solutions and broader distribution channels. Media Ventures continues to play a critical role in Germany’s media and tech ecosystem, fostering innovation and driving growth across digital and telecommunications markets.

Medicxi is a premier European venture capital firm specializing in life sciences, with a focus on drug discovery and therapeutic development. Established in 2016 by the former life sciences team of Index Ventures, the firm has raised over €1 billion across various funds. Medicxi’s flagship funds, such as Medicxi III (€400 million), invest in both early and late-stage biopharma companies. Notable investments include Genmab, Micromet (acquired by Amgen), and Minerva Neurosciences. Medicxi's investment strategy is centered around its "asset-centric" approach, where the firm invests in companies with strong clinical proof-of-concept that address clear unmet medical needs. Their investments typically range between €10 million and €25 million, supporting companies through key phases like clinical development and regulatory approval​. The firm partners closely with major pharmaceutical players such as Novartis, Johnson & Johnson, and GlaxoSmithKline, which provides strategic backing for its portfolio companies​. Headquartered in London, Geneva, and Jersey, Medicxi has become a leading name in European biotech, with a strong emphasis on translating scientific innovation into commercially viable drugs. Their portfolio spans across the full healthcare continuum, from early discovery to late-stage clinical assets, giving them a unique position in Europe’s life sciences ecosystem. Through its deep ties to industry leaders and a robust scientific advisory board, Medicxi continues to drive the next generation of breakthrough therapeutics​.

Manifold Ventures (MMV) is a venture capital firm focused on supporting early-stage companies in healthcare innovation. Founded by physicians and healthcare entrepreneurs, MMV invests in startups that are developing groundbreaking medical technologies and solutions. The firm is known for its hands-on approach, offering more than just capital; they provide strategic guidance, operational expertise, and access to an extensive network of industry professionals. Their portfolio includes companies like Stellation (patient-provider matching technology), PocketRN (telehealth nursing), and Gradient Health (a healthcare data marketplace). MMV's team, led by Dr. Branden Rosenhan and Dr. Saumitra Thakur, brings deep experience in both clinical practice and business, which they leverage to help their portfolio companies navigate the complexities of the healthcare industry. MMV is headquartered in Salt Lake City and focuses on identifying promising healthcare innovations early in their development cycle, with the goal of helping these startups scale into successful enterprises.

MedVenture Partners, Inc., a Tokyo-based venture capital firm, specializes in early-stage investments within the life sciences sector, with a distinct focus on medical devices and healthcare technologies. Established in 2013 by Hajime Oshita and Dr. Fumiaki Ikeno, the firm has rapidly built a reputation for identifying and nurturing innovative startups poised to disrupt the healthcare landscape. Their portfolio includes standout companies such as Biomedical Solutions, Inc., which exemplifies their commitment to fostering groundbreaking technologies. MedVenture’s investment strategy is characterized by a hands-on approach, often leading funding rounds and providing substantial guidance to portfolio companies. They prioritize startups that demonstrate strong potential for global impact, particularly those addressing critical medical needs. Their geographic focus remains largely on Japan, but they have shown interest in companies that can expand internationally. With over 22 billion Yen in assets under management, MedVenture manages multiple funds, the most recent of which raised 99 billion Yen. The firm’s approach to investment is strategic and collaborative, leveraging deep medical expertise alongside innovative technology. Startups seeking investment should be prepared to present compelling, well-researched pitches that highlight their innovation and market potential. Led by a team of seasoned professionals, including Oshita, who has over two decades of experience in the medical device industry, MedVenture Partners is committed to driving successful exits and significant market advances. Their active involvement in the growth and development of their portfolio companies underscores their role as a key player in Japan’s venture capital landscape.

Menlo Ventures, a Silicon Valley-based venture capital firm, has a robust history of investing in transformative technology companies across consumer, enterprise, and healthcare sectors. Notable investments include Uber, Roku, Warby Parker, Poshmark, and Chime. The firm focuses on early-stage investments but supports companies through their entire growth journey. Menlo Ventures recently closed a $1.35 billion fund aimed at backing the next generation of AI startups, reflecting its commitment to cutting-edge technologies. The firm also emphasizes deep involvement with portfolio companies, offering strategic guidance and support through every stage of development.

Merantix is a Berlin-based AI venture studio that has been building and investing in AI-driven startups since 2016. It operates Europe's largest AI platform, focusing on ideating, incubating, and scaling AI ventures across various industries. The company is notable for its emphasis on transformative AI applications, particularly in B2B sectors. Merantix has recently launched a €100 million fund, which is divided into three parts: €25 million for co-investing in external startups, €25 million for incubating new ventures, and €50 million for supporting existing investments. This marks a significant expansion from its traditional model, where it primarily incubated its own startups with an initial €1 million investment in exchange for equity. The firm has incubated successful companies like Vara, an AI breast cancer detection startup, and Cambrium, which focuses on AI-powered protein design. Merantix also hosts the AI Campus in Berlin, a 5,200 sqm co-working and community space dedicated to AI innovation, bringing together startups, corporations, and investors to foster collaboration. Merantix’s investment strategy focuses on early-stage companies, particularly in pre-seed and Series A rounds, with a strong emphasis on supporting founders who have deep domain expertise and a passion for AI.

Mercia Asset Management is a leading UK-based specialist asset manager that focuses on providing capital across four core asset classes: venture capital, private equity, debt, and balance sheet investments. Established initially as a seed capital provider linked to universities, it has grown to manage over £1.4 billion in assets, emphasizing support for small and medium enterprises (SMEs) across the UK, especially in underserved regional markets. The firm’s investment approach is built around its "Complete Connected Capital" model, which combines funds under management (FuM) with direct investments from its balance sheet. This hybrid strategy allows Mercia to offer flexible, long-term capital to startups and scale-ups, typically investing up to £10 million per round. Mercia's extensive portfolio covers sectors such as technology, healthcare, and advanced manufacturing, with notable investments in companies like Oxford Genetics and Netacea. Mercia operates nine regional offices, helping it maintain a close connection with local businesses, and collaborates with government bodies, institutional investors, and private individuals. The firm’s effective management of EIS (Enterprise Investment Scheme) and VCT (Venture Capital Trust) funds has enabled it to deliver consistent returns, achieving an average premium of around 53% on exits. Since its IPO in 2014, Mercia has demonstrated a solid track record in supporting the growth of UK regional businesses while delivering dividends to its investors, underpinning its strategy to be the top regional capital provider in the UK.

Mercia Asset Management, based in the UK, is a leading provider of venture, private equity, and debt financing, with a strong regional focus outside London. With over £1.5 billion in assets under management, Mercia actively backs early-stage businesses in sectors like AI, digital health, clean tech, and biosciences. Notable investments include Netacea (cybersecurity) and Nova Pangaea (sustainable aviation fuel), reflecting its commitment to high-growth sectors. Mercia typically invests between £500k to £20m, supporting startups through multiple stages of growth, including Seed to Series B. The firm’s focus on regional UK businesses helps address funding gaps, with 77% of their recent investments outside London. Their strategy prioritizes long-term partnerships with founders, often maintaining investments for five to seven years. The team, led by CEO Dr. Mark Payton, has a track record of successful exits, including the £100m sale of Faradion and the sale of nDreams to Aonic. Mercia's portfolio also benefits from its affiliation with major initiatives like the Northern Powerhouse Investment Fund, which helps accelerate regional growth. Mercia is known for being approachable and hands-on, offering mentorship alongside capital​.

Meridian Street Capital is a venture capital firm established in 2016, based in New York City. The firm specializes in early-stage investments at the intersection of healthcare and technology. Their approach is to support founders from the earliest stages, often from day one, to help turn innovative ideas into category-defining companies. Meridian Street Capital has a strong portfolio that includes companies like 1upHealth, ClosedLoop.ai, and Jona Health, among others. They focus on investing in businesses that leverage technology to improve healthcare services, access, and efficiency. Typically, their investments range from $100K to $5M, with a sweet spot around $1.5M. The firm has a hands-on approach, providing strategic guidance and leveraging their industry connections to support the growth of their portfolio companies. The team at Meridian Street Capital includes key figures such as George Ribaroff and T. Scott Law Jr., who bring extensive experience in venture capital and healthcare technology. They have a focused strategy, partnering with a concentrated group of startups to ensure dedicated support and resources. Meridian Street Capital has made a total of 47 investments and has seen several successful exits, including Valify and Hint Health. Their investment strategy emphasizes backing exceptional teams with innovative solutions that have the potential to transform healthcare.

Meron Capital, founded in 2017 and based in Tel Aviv, is an early-stage venture capital firm focused on investing in deep-technology software startups. The firm, led by managing partners Liron Azrielant and Daniel Roditi, has raised two funds, Meron I and Meron II, each with $50 million. Meron Capital primarily invests in sectors such as enterprise software, cybersecurity, digital health, fintech, and DevOps, targeting pre-seed and seed-stage companies. Notable investments by Meron Capital include Loom Systems, acquired by ServiceNow; Reshuffle, acquired by Twitter; Clear Genetics, acquired by Invitae; and Axonize, acquired by Planon. The firm’s current portfolio also includes promising startups like LendAI, Sorbet, Firmbase, and Laminar​. Meron Capital prides itself on a founder-first approach, providing not just capital but also strategic guidance and leveraging their extensive network to help startups scale. They emphasize backing resilient and technically proficient founders who are capable of pushing through challenges and leveraging subtle expert feedback to refine their business models​.

Merus Capital, founded in 2008 and based in Palo Alto, California, focuses on early-stage investments, primarily from pre-seed to Series A rounds. The firm specializes in sectors such as HR tech, big data and analytics, artificial intelligence and machine learning, biotech, and developer tools. Merus Capital has made 104 investments and has had 30 successful exits, including notable companies like Amplitude, Iterable, and Symphony​. Other prominent portfolio companies include Emi Labs, Censia, Moesif, and Modern Health​. Co-founded by Sean Dempsey, Salman Ullah, and Peter Hsing, Merus Capital aims to support ambitious teams that are building industry-defining platforms. The firm offers substantial follow-on capital and leverages its extensive network to help portfolio companies scale effectively​.

Metaplanet Holdings, founded in 2011 by Jaan Tallinn, co-founder of Skype, is a venture capital firm based in Tallinn, Estonia. The firm focuses on early-stage investments in deep technology startups that promise long-term societal and civilizational impacts. Metaplanet emphasizes funding science-heavy projects and non-commercial research aimed at reducing existential risks, particularly from AI and other advanced technologies. Metaplanet has a diversified portfolio of over 150 startups, with notable investments including BillionToOne, a provider of cell-free cancer liquid biopsy tests, and Anthropic, an AI-based conversational chatbot service. The firm has made more than 50 successful exits, including companies like Ampler Bikes and Apprente. Recent investments include $7 million in the blockchain company Fhenix and $13 million in Neurable, a brain-computer interface technology company. The firm's investment strategy focuses on sectors such as AI, neuroscience, blockchain, and encryption, supporting innovations that have the potential to disrupt industries or create entirely new ones. Metaplanet's team, led by Managing Partner Rauno Miljand and Partner Alexey Morgunov, operates with a lean structure, enabling them to make impactful and strategic investments.

Metavallon VC, founded in 2018 and based in Athens, Greece, focuses on early-stage investments in technology startups, particularly those connected to Greece. They typically invest in seed and pre-seed stages, with initial funding tickets ranging from €500K to €1.5M. The firm emphasizes supporting startups in sectors like transportation and mobility, energy and cleantech, space and aviation, machine learning and AI, and more. Notable investments by Metavallon VC include Ferryhopper, a leading ferry booking platform, and Wikifarmer, which aims to democratize agricultural commerce. The firm has also successfully exited from companies such as Seervision, which specializes in AI-driven camera automation software, and Think Silicon, a provider of graphics technology solutions. Metavallon VC offers extensive support to their portfolio companies, including business development, B2B sales, recruiting, and exit planning. Their approach combines financial backing with hands-on guidance to help startups scale and achieve significant market impact. The leadership team includes George Karantonis, Myrto Papathanou, and Yorgos Mousmoulas, who bring extensive experience in venture capital and technology investments.

Metrodora Ventures is a New York-based venture capital firm founded in 2020 by Chelsea Clinton. The firm focuses on early-stage investments in the health and learning sectors, with a mission to support companies that improve access to care, education, and vital information. Metrodora Ventures is driven by a values-conscious approach, investing in purpose-driven startups that aim to make a significant impact on society. The firm’s portfolio includes innovative companies like Teal Health, which is developing telehealth platforms focused on women’s health, and Blooming Health, which creates technology to help older adults maintain connections with their communities. Another notable investment is Swing Therapeutics, which develops digital therapies for chronic illness management. Metrodora Ventures operates with the goal of nurturing its portfolio companies by providing capital, market insights, and industry relationships. The firm raised its debut fund of $20.8 million and is currently in the process of raising a second fund to continue its mission of fostering impactful startups.

Noshaq is an investment fund based in Liège, Belgium, that offers a range of financing solutions aimed at fostering the creation and growth of companies, particularly SMEs. Established in 1985 under the name Meusinvest, the organization has grown significantly and rebranded to Noshaq in 2019 to better reflect its innovative and dynamic approach to investment. Noshaq manages a portfolio of 477 companies and has supported over 1,020 companies since its inception. The fund's primary focus areas include biotechnology, industry 4.0, digital technology, quality food, real estate, energy, sustainable development, and cultural industries. They provide funding through various vehicles, including equity investments, loans, and leasing, tailored to the specific needs of each stage of a company's development. Notable initiatives under Noshaq include Noshaq Spin-Offs, which supports the creation of spin-offs in collaboration with the University of Liège, and LeanSquare, which focuses on innovative projects in cultural and creative industries, enterprise software, and life sciences. Additionally, Noshaq is actively involved in regional development projects, such as La Grand Poste, a creative hub in the heart of Liège.

MHS Capital, founded in 2006 and based in San Francisco, California, focuses on early-stage investments in technology-driven companies. They have a diverse portfolio, investing across sectors such as software, e-commerce, mobile, and healthcare. Notable investments include companies like Zenput, a business productivity software, and Grove Collaborative, an eco-friendly consumer goods company. MHS Capital has made a total of 102 investments, with 48 successful exits, including companies like Udemy and Thumbtack. The firm emphasizes close collaboration with visionary founders to build the next generation of category-defining companies.

mHUB, based in Chicago, is a leading innovation center for hardtech and manufacturing startups. Founded in 2017, mHUB has quickly established itself as a key player in driving innovation across various sectors, including climate tech, medtech, and smart manufacturing. Through its Product Impact Fund I, mHUB has invested in 46 startups, with a significant focus on sustainable manufacturing and clean energy technologies. Notable investments include Sensatek Propulsion Technology, Aeternal Upcycling, and Next-Ion, among others. mHUB’s strategic approach combines capital investment with robust support through its accelerator programs, providing startups with access to extensive prototyping labs, a vast network of industry mentors, and business leadership training. The mHUB community has generated over $1.89 billion in revenue, launched more than 1,600 products, and created over 5,500 jobs since its inception. The organization’s commitment to diversity is evident, with investments in underrepresented founders being 6.5 times higher than the national average. Key team members like Haven Allen, CEO and co-founder, and Melissa Lederer, Chief Experience Officer, play pivotal roles in steering the fund and supporting its portfolio companies towards commercialization and market success. Situated at the intersection of Chicago’s tech and manufacturing districts, mHUB leverages its location within an Opportunity Zone and Planned Manufacturing District to offer unique benefits to startups, such as eligibility for specific funding opportunities and federal contracts. With its new 80,000 square foot facility, mHUB continues to expand its capacity to support innovation and drive economic growth in the region.

Miami Angels, founded in 2013, is one of Florida's largest and most active angel networks. The group focuses on post-product, post-revenue, early-stage technology companies, and is industry agnostic. Their portfolio includes over 60 companies with more than $32 million invested. The organization works through its individual members, who make investments rather than the network itself. This allows for a diverse range of opportunities and perspectives within the tech startup ecosystem. Miami Angels supports various startups, including Caribu, Nearpod, and ClassTag, which span industries from educational technology to enterprise solutions​. Miami Angels values partnerships and collaborations, which help provide exceptional services and support to the companies in their network. Key partners include Kaufman Rossin, a leading accounting and advisory firm.

Middle East Venture Partners (MEVP) is one of the largest and most established venture capital firms in the Middle East, with a focus on investing in early and growth-stage technology startups across the GCC and Levant regions. Founded in 2010, MEVP manages over $300 million in assets and has invested in more than 60 startups, many of which operate in sectors such as fintech, e-commerce, mobility, SaaS, and healthtech. With offices in Dubai, Beirut, Bahrain, and Riyadh, MEVP targets innovative companies that have the potential to scale regionally and globally. Their portfolio includes successful companies like Anghami, the first legal music streaming platform in the Arab world to go public, Nana, a leading online grocery delivery service, and Bykea, a Pakistani super app offering transport and delivery services. MEVP offers both financial backing and strategic support to help these businesses grow, focusing on building sustainable, scalable models that align with local market needs. MEVP has also made significant exits, such as its partial exit from Fresha, a beauty and wellness platform, generating impressive returns. With its recent launch of the $150 million Middle East Venture Fund IV, MEVP continues to drive innovation by supporting digital services and tech-based solutions that address local challenges and tap into global trends​.

Middleland Capital, a venture capital firm founded in 2010 and based in Washington, D.C., focuses on innovative foodtech and agtech companies. With over $100 million invested and a portfolio of 25 direct investments, the firm supports high-growth companies that are looking to scale their de-risked technology and proven business models​. The firm's notable investments include AeroFarms, the largest indoor vertical farming company in the US; Soli Organic, a leading grower and marketer of fresh organic culinary herbs; and MycoTechnology, an ingredient company that utilizes proprietary processes to remove flavor defects in food products without chemicals or GMOs​​. Other significant investments include EarthOptics, which provides real-time soil data maps, and Farmwise, which develops systems to streamline farming operations and increase food production efficiency​. Middleland Capital has a strong track record of successful exits, such as Seventh Generation, which was acquired by Unilever, and Benson Hill, which went public on the NYSE. The firm continues to catalyze global change in food and health through its targeted investments in innovative technologies and sustainable solutions.

MIG AG, based in Munich, Germany, is a prominent venture capital firm investing primarily in deep tech and life sciences. Their notable portfolio includes BioNTech, renowned for its COVID-19 vaccine, and companies like German Bionic, developing exoskeletons, and iOmx Therapeutics, focusing on novel cancer treatments. With over €1.2 billion in committed capital, MIG AG targets early to mid-stage startups that drive technological advancements and societal benefits. Their strategy is to invest in companies with groundbreaking innovations in biopharmaceuticals, medical technology, digital health, advanced computing, and environmental tech. MIG AG is known for its rigorous due diligence and active involvement in portfolio companies, providing strategic support and leveraging an extensive network to foster growth. Key team members include co-founders Jürgen Kosch and Michael Motschmann, both based in Munich, who bring decades of experience in venture capital and entrepreneurship. Startups can approach MIG AG through direct contact or their extensive industry network, emphasizing innovative solutions with strong growth potential. For entrepreneurs seeking investment, MIG AG values clear, impactful pitches that demonstrate significant technological breakthroughs and market readiness.

Millennium Global Opportunities is a Luxembourg-based mixed-asset fund managed by Millennium FT. It offers investment opportunities to both mutual and institutional investors, with tailored fee structures for each group. The fund adopts an opportunistic investment strategy, actively managing a diverse portfolio that includes equities, currencies, interest rates, and futures. It also prioritizes risk management to capitalize on global trends while minimizing potential downsides. Since 2018, Millennium Global Opportunities has integrated environmental, social, and governance (ESG) factors into its investment decision-making process, reflecting a commitment to sustainability. The fund’s focus on sustainability aligns with the broader global shift towards responsible investing, as it aims to generate positive financial returns while considering the long-term environmental and social impacts of its investments. The fund currently manages over €25 million in assets and targets growth through investments in large-cap stocks, as well as sustainable assets. Key holdings in the fund's portfolio include Xetra-Gold, U.S. Treasury Notes, and other high-quality assets that offer both security and potential for appreciation. Millennium Global Opportunities has also earned recognition in the investment community, winning multiple Lipper Fund Awards for excellence in the Absolute Return category. Millennium FT's active management approach, combined with a strong focus on sustainability and risk mitigation, makes it a versatile investment vehicle for those looking to balance growth with responsibility. The fund is particularly well-suited for investors who are seeking to diversify their portfolios with a blend of traditional and sustainable assets.

Milltrust International Group is a specialist investment firm co-headquartered in London and Singapore, known for its focus on sustainable investment strategies. The firm manages assets across public and private markets, with a particular emphasis on addressing global challenges such as food security, climate change, and emerging economies. Their investment philosophy, termed "Sustainable Prosperity," integrates wealth creation with ethical, planet-friendly goals. Milltrust operates through several branches, including Milltrust Ventures, which focuses on venture capital investments in sectors like healthcare, technology, and sustainable agriculture. The firm also manages East West Private Wealth, a multi-family office dedicated to wealth management services that align with eco-conscious and transparent investment strategies. This diverse approach allows Milltrust to support both institutional investors and high-net-worth families globally. In recent years, Milltrust has invested in impactful projects such as sustainable agricultural land in Australia and New Zealand, and high-growth technology companies that promote environmental sustainability.